Evidence map›Paper›PMID 40302135›Full record

GuidelineJournal of evidence-based medicine2025

Clinical Application Guideline of Combination With Traditional Chinese Medicine and Western Medicine in the Prevention and Treatment of Chronic Obstructive Pulmonary Disease (2024).

Di Wu, Wei Liu, Jianxin Wang, Wei Chen, Mengyao Shi, Lu Zhang, Hui Wang, Huanzhang Ding, Xiao Ma, Yating Gao and 8 more

Abstract readPractice Guideline
In one paragraph

Guideline in Journal of evidence-based medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Machine Learning Modeling forFoods (Basel, Switzerland) · 2026
    Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Di WuDepartment of Traditional Chinese Medicine, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, China.ORCID https://orcid.org/0000-0002-3150-5242
Wei LiuDepartment of Integrated Traditional and Western Medicine, West China Hospital, Sichuan University, Chengdu, China.
Jianxin WangDepartment of Evidence-Based Traditional Chinese Medicine, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China.ORCID https://orcid.org/0000-0001-6322-3154
Wei ChenCentre for Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.
Mengyao ShiDepartment of Traditional Chinese Medicine, Anhui University of Chinese Medicine, Hefei, China.
Lu ZhangDepartment of Traditional Chinese Medicine, Anhui University of Chinese Medicine, Hefei, China.
Hui WangDepartment of Traditional Chinese Medicine, Anhui University of Chinese Medicine, Hefei, China.
Huanzhang DingThe Affiliated First Hospital of Fuyang Normal University, Fuyang Normal University Fuyang Anhui, Fuyang, China.
Xiao MaDepartment of Respiratory and Critical Care Medicine, Wuhu Hospital of Traditional Chinese Medicine, Wuhu, China.
Yating GaoDepartment of Traditional Chinese Medicine, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, China.
Zengtao SunInstitute of Pyreticosis and Respiratory Diseases, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
Jiangtao LinPulmonary and Critical Care Medicine, China-Japan Friendship Hospital, Beijing, China.
Hongchun ZhangClinical Research Center for Respiratory Diseases, China-Japan Friendship Hospital, Beijing, China.
Suyun LiDepartment of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, China.
Zhuying LiDepartment of Respiratory Medicine, The First Affiliated Hospital of Heilongjiang University of Traditional Chinese Medicine, Herbin, China.
Zhenhui LuInstitute of Respiratory Diseases, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Fuqiang WenDepartment of Respiratory and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, China.
Zegeng LiDepartment of Traditional Chinese Medicine, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, China.

Funding

National Administration of Traditional Chinese Medicine SATCM-2015-BZ[402]National Health Commission's Healthy China Initiative's Key Project with Leading Roles and Responsibilities JKZGJBGG2331Standardization Project of the "Clinical Application Guidelines for the Treatment of Diseases with Advantages in Traditional Chinese Medicine (TCM) Preparations"the Chinese Medicine Standardization Project of the Policy, Regulation and Supervision Department of the National Administration of Traditional Chinese Medicine GZY-FJS-2022-040the General Program of the National Natural Science Foundation of China 82374399the Joint Fund for Regional Innovation and Development U20A20398the National Natural Science Foundation of China
6 · The paper itself

Abstract

aimChronic Obstructive Pulmonary Disease (COPD) is a common chronic airway disease that can lead to decreased lung function in patients. It places a heavy economic burden on patients and society. Traditional Chinese medicine (TCM) and Western medicine have played important roles in managing COPD. We aimed to develop an evidence-based guideline for treating COPD with Chinese and Western Medicine.

methodsWe formed a guideline panel of multidisciplinary experts. The clinical questions were identified based on two rounds of issue solicitation and expert demonstration. We searched the literature for direct evidence on the management of COPD and assessed its certainty-generated evidence using the grading of recommendations, assessment, development, and evaluation (GRADE) approach. The recommendations and their strengths were formulated using the Delphi method.

resultsOur guideline covers aspects of the diagnosis and treatment of COPD such as principles and commonly used medications for both traditional Chinese medicine and Western medicine, complications, and the high-risk populations. 9 clinical questions and 35 recommendations were identified, which covered the combinations of YuPingFeng granule, Buzhong Yiqi decoction, Gushen Dingchuan Pill, Bufei Huoxue Capsules, Runfei cream, Bailing Capsule, Tanyin Pills, etc., and nonpharmacological therapy of TCM such as combined acupoint application, electroacupuncture, and Chinese exercise techniques (Tai Chi, Baduanjin), etc. Recommendations were either high or low or in the form of ungraded consensus-based statements.

conclusionsThis is a comprehensive and systematic evidence-based guideline and we hope it can systematically and effectively guide clinicians in managing COPD and improve overall medical care.

Indexed as

Drugs, Chinese HerbalMedicine, Chinese TraditionalPulmonary Disease, Chronic ObstructiveEvidence-Based MedicineHumansDrugs, Chinese Herbalchronic obstructive pulmonary diseaseevidence‐based guidelineintegrating Chinese and western medicinerecommendationtraditional Chinese medicine

Identifiers

PMID40302135
PMCPMC12041629

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.